A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Advanced-stage tongue squamous cell carcinoma: a machine learning model for risk stratification and treatment planning
Tekijät: Alabi Rasheed Omobolaji, Elmusrati Mohammed, Leivo Ilmo, Almangush Alhadi, Mäkitie Antti A
Kustantaja: Taylor & Francis
Julkaisuvuosi: 2023
Journal: Acta Oto-Laryngologica
Tietokannassa oleva lehden nimi: ACTA OTO-LARYNGOLOGICA
Lehden akronyymi: ACTA OTO-LARYNGOL
Vuosikerta: 143
Numero: 3
Aloitussivu: 206
Lopetussivu: 214
Sivujen määrä: 9
ISSN: 0001-6489
eISSN: 1651-2251
DOI: https://doi.org/10.1080/00016489.2023.2172208
Verkko-osoite: https://www.tandfonline.com/doi/full/10.1080/00016489.2023.2172208
Background
A significant number of tongue squamous cell carcinoma (TSCC) patients are diagnosed at late stage.
Objectives
We primarily aimed to develop a machine learning (ML) model based on ensemble ML paradigm to stratify advanced-stage TSCC patients into the likelihood of overall survival (OS) for evidence-based treatment. We compared the survival outcome of patients who received either surgical treatment only (Sx) or surgery combined with postoperative radiotherapy (Sx + RT) or postoperative chemoradiotherapy (Sx + CRT).
Material and Methods
A total of 428 patients from Surveillance, Epidemiology, and End Results (SEER) database were reviewed. Kaplan-Meier and Cox proportional hazards models examine OS. In addition, a ML model was developed for OS likelihood stratification.
Results
Age, marital status, N stage, Sx, and Sx + CRT were considered significant. Patients with Sx + RT showed better OS than Sx + CRT or Sx alone. A similar result was obtained for T3N0 subgroup. For T3N1 subgroup, Sx + CRT appeared more favorable for 5-year OS. In T3N2 and T3N3 subgroups, the numbers of patients were small to make insightful conclusions. The OS predictive ML model showed an accuracy of 86.3% for OS likelihood prediction.
Conclusions and Significance
Patients stratified as having high likelihood of OS may be managed with Sx + RT. Further external validation studies are needed to confirm these results.